A carregar...
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
Cholesteryl ester transfer protein (CETP) inhibitors significantly increase serum high-density lipoprotein cholesterol (HDL) cholesterol levels and decrease low-density lipoprotein cholesterol (LDL) cholesterol concentration. However, three drugs of this class failed to show a decrease of cardiovasc...
Na minha lista:
| Publicado no: | Diseases |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5750532/ https://ncbi.nlm.nih.gov/pubmed/28961179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diseases5040021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|